Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients

Lopez-Diaz, Maria J.; Barros, Sônia; Garcı́a-Porrúa, Carlos; Sánchez-Andrade, A; Paz-Carreira, Jose; Martín, Javier; Llorca, Javier

doi:10.1016/j.ajo.2006.04.004

Cited by 44 publications

(67 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…20,21 Polymyalgia rheumatica and giant cell arteritis can mimick other conditions, with features such as thrombocytosis and leukocytosis, with patients being misclassified as myeloproliferative neoplasms. 22,23 However, in our latency analyses on polymyalgia rheumatica we found the risk estimate to be significantly elevated more than five years prior to myeloproliferative neoplasms. Furthermore, aplastic anemia, characterized by pancytopenia and reduced marrow cellularity, is treated with immunosuppressive therapy and/or stem cell transplantation.…”

Section: Resultsmentioning

confidence: 81%

Autoimmunity and the risk of myeloproliferative neoplasms

Kristinsson¹,

Landgren²,

Samuelsson³

et al. 2010

Haematologica

163

126

View full text Add to dashboard Cite

doi:10.3324/haematol.2009.020412 Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid dissemination of science. Haematologica is, therefore, E-publishing PDF files of an early version of manuscripts that have completed a regular peer review and have been accepted for publication. E-publishing of this PDF file has been approved by the authors. After having E-published Ahead of Print, manuscripts will then undergo technical and English editing, typesetting, proof correction and be presented for the authors ' final approval; the final version of the manuscript will then appe-ar in print on a regular issue of the journal. All legal disclaimers that apply to the journal also pertain to this production process. Haematologica (pISSN: 0390-6078, eISSN: 1592-8721, NLM ID: 0417435, www.haemato-logica.org) publishes peer-reviewed papers across all areas of experimental and clinical hematology. The journal is owned by the Ferrata Storti Foundation, a non-profit organiza-tion, and serves the scientific community with strict adherence to the principles of open access publishing (www.doaj.org). In addition, the journal makes every paper published immediately available in PubMed Central (PMC), the US National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature. Official Organ of the European Hematology Association Published by the Ferrata Storti Foundation, Pavia, Italy www.haematologica.or

show abstract

Section: Resultsmentioning

confidence: 81%

Autoimmunity and the risk of myeloproliferative neoplasms

Kristinsson¹,

Landgren²,

Samuelsson³

et al. 2010

Haematologica

163

126

View full text Add to dashboard Cite

show abstract

“…20,21 Interestingly, in a population-based study on a series of biopsy-proven GCA, only 1 (0.4%) out of 240 patients had an ESR lower than 40 mm/1st hour, and the median ESR value was 93 mm/1st hour. 22 Also, in that series, 17 (48.8%) of the 240 biopsy-proven GCA patients had platelet counts higher than greater than 400 000/mm 3 . This study also confirmed a strong correlation among most laboratory markers of inflammation at the time of disease diagnosis in GCA.…”

Section: % (13|13)mentioning

confidence: 99%

Ocular pulse amplitude as a diagnostic adjunct in giant cell arteritis

Knecht

Bachmann

Thiel

et al. 2015

Eye

View full text Add to dashboard Cite

“…There was also thrombocytosis, leukocytosis, microcytic and normochromic anemia, increase of transaminases and plasma protein electrophoresis compatible with the diagnosis of GCA and observed in cases subject to complications 11 .…”

Section: Discussionmentioning

confidence: 98%

Arterite de células gigantes coronariana e infarto agudo do miocárdio

Godoy¹,

Araújo²,

Júnior³

et al. 2007

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

Giant cell arteritis (GCA) is a systemic immune-mediated granulomatous vasculitis of large-and medium-sized arteries mainly affecting elderly people. Death from GCA alone is rare and usually results of ruptured aorta. In this paper is reported a case of a 83-year-old woman who unexpectedly died during treatment of GCA. Necropsy revealed inflammatory involvement of the coronary arteries with left descendent anterior artery thrombosis, myocardial infarct and rupture of the anterior wall of the left ventricle, as well as hemopericardium and cardiac tamponade. Myocardial infarction leading to sudden death is an exceptional complication of GCA.

show abstract

Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients

Cited by 44 publications

References 0 publications

Autoimmunity and the risk of myeloproliferative neoplasms

Autoimmunity and the risk of myeloproliferative neoplasms

Ocular pulse amplitude as a diagnostic adjunct in giant cell arteritis

Arterite de células gigantes coronariana e infarto agudo do miocárdio

Contact Info

Product

Resources

About